Vitamin K2 Inhibits Hepatocellular Carcinoma Cell Proliferation by Binding to 17β-Hydroxysteroid Dehydrogenase 4
Our previous studies have proved that 17β-hydroxysteroid dehydrogenase 4 (HSD17B4) is a novel proliferation-promoting protein. The overexpression of HSD17B4 promotes hepatocellular carcinoma (HCC) cell proliferation. Vitamin K2 (VK2), a fat-soluble vitamin, has the function of promoting coagulation...
Guardado en:
Autores principales: | Xin Lu, Panpan Ma, Lingyu Kong, Xi Wang, Yaqi Wang, Lingling Jiang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f32344f05f4f462f865c059c2e3ecea0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of mitochondrial iron uptake in HepG2 cells
por: MAZARIEGOS,DORA INÉS, et al.
Publicado: (2006) -
Differential p16 expression levels in the liver, hepatocytes and hepatocellular cell lines
por: Barbara Kramar, et al.
Publicado: (2021) -
In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine
por: Li S, et al.
Publicado: (2017) -
Polyethylene glycol–poly(ε-benzyloxycarbonyl-L-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma
por: Wang GM, et al.
Publicado: (2017) -
Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier
por: Lv Y, et al.
Publicado: (2017)